IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
- PMID: 29665983
- PMCID: PMC5939989
- DOI: 10.1016/j.molmed.2018.03.005
IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways responsible for the activation of IL-1 family cytokines are key in the development of NAFLD but underlying mechanisms are not fully understood. Many studies have focused on the inflammasome-caspase-1 pathway and have shown that this pathway is an important inducer of inflammation in NAFLD. However, this pathway is not solely responsible for the activation of proinflammatory cytokines. Also, neutrophil serine proteases (NSPs) are capable of activating cytokines and recent studies reported that these proteases also contribute to NAFLD. These studies provided, for the first time, evidence that this inflammasome-independent pathway is involved in NAFLD. In our opinion, these new insights open up new approaches for therapeutic intervention.
Keywords: inflammasome; inflammation; interleukin-1; neutrophil serine proteases; nonalcoholic fatty liver disease; obesity.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare to have no competing interests
Figures
Comment in
-
Effect of dapagliflozin against NAFLD and dyslipidemia in type 2 diabetic albino rats: possible underlying mechanisms.Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8101-8109. doi: 10.26355/eurrev_202309_33570. Eur Rev Med Pharmacol Sci. 2023. PMID: 37750638
Similar articles
-
Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease.FASEB J. 2018 Feb;32(2):757-767. doi: 10.1096/fj.201700602R. Epub 2018 Jan 4. FASEB J. 2018. PMID: 28970254
-
Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.J Physiol Biochem. 2018 Nov;74(4):503-510. doi: 10.1007/s13105-018-0644-y. Epub 2018 Jul 17. J Physiol Biochem. 2018. PMID: 30019185
-
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study.Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101843. doi: 10.1016/j.clinre.2021.101843. Epub 2021 Dec 16. Clin Res Hepatol Gastroenterol. 2022. PMID: 34922061 Clinical Trial.
-
Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Hepatology. 2016 Sep;64(3):955-65. doi: 10.1002/hep.28456. Epub 2016 Mar 9. Hepatology. 2016. PMID: 26773297 Review.
-
Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target.Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101710. doi: 10.1016/j.clinre.2021.101710. Epub 2021 Apr 27. Clin Res Hepatol Gastroenterol. 2021. PMID: 33930586 Review.
Cited by
-
Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis.Front Cell Dev Biol. 2024 Jul 12;12:1431921. doi: 10.3389/fcell.2024.1431921. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39071804 Free PMC article. Review.
-
Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity.Int J Mol Sci. 2022 Aug 30;23(17):9871. doi: 10.3390/ijms23179871. Int J Mol Sci. 2022. PMID: 36077270 Free PMC article.
-
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.Front Immunol. 2021 Feb 9;11:634409. doi: 10.3389/fimmu.2020.634409. eCollection 2020. Front Immunol. 2021. PMID: 33633748 Free PMC article. Review.
-
MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice.Int J Mol Sci. 2019 Dec 3;20(23):6084. doi: 10.3390/ijms20236084. Int J Mol Sci. 2019. PMID: 31816816 Free PMC article.
-
Antioxidant and Immunomodulatory Properties of Chia Protein Hydrolysates in Primary Human Monocyte-Macrophage Plasticity.Foods. 2022 Feb 22;11(5):623. doi: 10.3390/foods11050623. Foods. 2022. PMID: 35267256 Free PMC article.
References
-
- European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of hepatology. 2016;64(6):1388–402. - PubMed
-
- Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, Hashinaga T, et al. Pivotal Role of TNF-alpha in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model. Horm Metab Res. 2017 - PubMed
-
- Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nature reviews Gastroenterology & hepatology. 2015;12(7):387–400. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
